-
XECARB® thermoplastic composites used in BFT motors
Time of Update: 2023-01-15
Its new products, AC A 40 and BT A 40 models, have enhanced durability, reliability and quiet operation thanks to the application of XECARB® thermoplastic composites, a new unique gear made from it, replacing the previous POM plastic .
-
Domestic and foreign pharmaceutical companies are achieving "win-win" through cooperation
Time of Update: 2022-12-30
On December 16, Zhejiang Daoer Biotechnology Co. , Ltd. announced that it has reached a clinical trial cooperation agreement with Merck to explore the clinical trial of Doyle Biologics anti-Claudin18
-
Nature Biotechnology: m6A single-base quantitative sequencing detection method
Time of Update: 2022-11-14
On October 27, 2022, Professor Yi Chengji's research group of the School of Life Sciences of Peking University and the research group of Wang Jing, a researcher from the School of Pharmacy of Peking
-
ANBR Review of hydrogel-based biomaterials for immune system regulation
Time of Update: 2022-10-20
In a 2021 article published in Advanced NanoBiomed Research, Tay Kah Ping's team in the Department of Biomedical Engineering at the National University of Singapore reviewed the rationale for hydrogel-based biomaterials to reprogram the immune system in recent years.
-
Achievements of the ES&T cover series of Qiu Rongliang's team of Sun Yat-sen University: Migration behavior and microscopic mechanism of environmental microorganisms in porous media
Time of Update: 2022-10-13
Click on the blue letter above Follow usFirst author: Jin ChaoCorresponding author: Qiu RongliangCommunications: School of Environmental Science and Engineering, Sun Yat-sen UniversityDissertation DOI
-
DuPont Photovoltaic Solutions Releases New Fortasun™ Photovoltaic Silicone Material
Time of Update: 2022-08-17
Dan Barish, Global Business Manager for TCS and Photovoltaic Silicones, said, "Fortasun™, a new line of silicone products, stands for high quality and reliability, and delivers the same reliable performance as our Tedlar® and Solamet® brands with over 30 years of outdoor provenance .
-
The license transaction will continue to be hot Fosun Pharma acquires the rights of an oncology drug in China
Time of Update: 2022-08-12
According to statistics, in 2021, there will be a total of 128 license in transactions in China's pharmaceutical industry, most of which are introduced through the rights and interests of innovative drug projects .
-
J Hepatol (IF=25) Ye Qinghai/Ren Ning/Guo Lei/Li Hui/Hong Mingqi discovered a new strategy to enhance immune checkpoint therapy in hepatocellular carcinoma
Time of Update: 2022-03-07
In conclusion, this study finds that PARG acts as an oncogene in HCC by regulating PARG/DDB1/c-Myc signaling and can be used as a biomarker to identify HCC patients who may benefit from anti-PD-1 therapy .
-
Professor Zou Dajin: Principles of Prevention and Treatment of Common "Adverse Reactions" of SGLT2i
Time of Update: 2022-02-21
Based on the accumulation of rich evidence-based medical evidence and clinical practice experience, the recommendation status of SGLT2i in domestic and foreign guidelines/consensus has been continuously improved in recent years .
Recently, Yimaitong has the honor to invite Professor Zou Dajin to live online to answer your questions.
-
Gansu improves the level of drug security: new anti-tumor drugs will continue to enter medical insurance
Time of Update: 2022-01-24
At the meeting, Yang Wenbin, director of the Planning, Finance, Policy and Regulation Division of the Gansu Provincial Medical Security Bureau , said in response to reporters' questions that it is necessary to improve the level of treatment for major diseases and the guarantee of medication for special groups, innovate the way of negotiating the guarantee of drug supply, and establish and improve "dual-channel" management.
-
At the end of the year, the wave of mergers and acquisitions of pharmaceutical companies continued
Time of Update: 2021-12-26
In recent years, due to the difficulty, time-consuming, labor-intensive, and costly research and development of new drugs, many pharmaceutical companies have vigorously made some new investment arrangements in order to increase corporate operating profits, enrich drug pipelines, and reduce R&D expenditures .
-
What aspects should be paid attention to in the selection of water-based coating additives
Time of Update: 2021-12-26
The surface tension of the defoamer must be lower than the surface tension of the coating, otherwise it will not have the effect of defoaming and foam suppression .
The foam in these coatings is quite difficult to eliminate, it is best to use defoamers and defoamers together .
-
Start-up of Clariant's ammonia synthesis catalyst project
Time of Update: 2021-12-24
Recently, Clariant announced that its new-generation AmoMax 10 Plus ammonia synthesis catalyst has been successfully driven at BASF's ammonia plant in Antwerp, Belgium.
™ It is understood that AmoMax 10 Plus is Clariant's latest generation of ammonia synthesis catalyst based on the structure of wustite .
-
Hutchison Pharmaceuticals and Epizyme cooperate to develop and commercialize TAZVERIK in Greater China
Time of Update: 2021-08-29
Hutchison Medicine will also participate in Epizyme's global registration study of TAZVERIK® combined with R2 in the treatment of second-line follicular lymphoma, the EZH-302 study, and lead the study in Greater China .
-
Journal of Stroke: Tiantan Hospital: What are the risk factors for recurrent stroke
Time of Update: 2021-08-04
Blood vesselIn this way, Yuesong Pan and others of Beijing Tiantan Hospital used the prospective registration data (Third China National Stroke Registry, CNSR-III) of patients with acute ischemic stroke and TIA across China to evaluate adherence to the guideline-based secondary The risk of recurrence of acute ischemic stroke or TIA for stroke prevention, and the risk factors for residual risk are determined .
